SCHEMBL8523994

SCHEMBL8523994

CCN(CC)CC#CCCC(=O)C(O)(c1ccccc1)C1CCCCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.68
CHRM1 P11229 4/20 0.68
CHRM4 P08173 3/20 0.68
CHRM3 P20309 3/20 0.68
CYP2C19 P33261 2/20 0.68
KCNH2 Q12809 2/20 0.68
SLC6A3 Q01959 2/20 0.68
CYP1A2 P05177 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
PKM P14618 1/20 0.68
NFKB1 P19838 1/20 0.68
THPO P40225 1/20 0.68
ABCB11 O95342 1/20 0.68
ESR1 P03372 1/20 0.68
CHRM5 P08912 1/20 0.68
ADRA2A P08913 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
TBXA2R P21731 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9618887 0.99 CYP2C19 (0.66) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9618884 0.94 CYP2C19 (0.59) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL8338552 0.93 CHRM2 (0.59) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9809592 0.92 CHRM2 (0.58) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9809567 0.91 CHRM3 (0.55) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL7913118 0.91 CHRM3 (0.55) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9809464 0.91 CHRM3 (0.55) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9809558 0.90 CHRM3 (0.55) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9618849 0.90 ALDH1A1 (0.54) CHRM2CHRM1CHRM4CHRM3CYP2C19
SCHEMBL9619016 0.89 CHRM2 (0.55) CHRM2CHRM1CHRM4CHRM3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915826-A4 SMOOTH MUSCLE SPASMOLYTIC AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF BRIDGE PHARMA INC (US) 1999-12-29 EP disclosed
EP-0915826-A1 SMOOTH MUSCLE SPASMOLYTIC AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF Bridge Pharma, Inc. (US) 1999-05-19 EP disclosed
WO-1998000390-A1 SMOOTH MUSCLE SPASMOLYTIC AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF BRIDGE PHARMA, INC. (US) 1998-01-08 WO disclosed
EP-0251126-B1 1,7-SUBSTITUTED HEPTYNE-2-ONES MARION MERRELL DOW INC. (US) 1992-01-08 EP disclosed
US-5036107-A Treatment of neurogenic bladder disorders MARION MERRELL DOW INC. (US) 1991-07-30 US disclosed
EP-0251126-A2 1,7-substituted heptyne-2-ones MARION MERRELL DOW INC. (US) 1988-01-07 EP disclosed